Search Results

There are 19297 results for: content related to: Systemic treatment of early breast cancer—a biological perspective

  1. Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

    Biotechnology and Bioengineering

    Volume 112, Issue 6, June 2015, Pages: 1102–1110, Jaina M. Patel, Vincent F. Vartabedian, Min-Chul Kim, Sara He, Sang-Moo Kang and Periasamy Selvaraj

    Version of Record online : 17 APR 2015, DOI: 10.1002/bit.25537

  2. You have full text access to this OnlineOpen article
    Analysis of different HER-2 mutations in breast cancer progression and drug resistance

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 12, December 2015, Pages: 2691–2701, Zijia Sun, Yaqin Shi, Yan Shen, Lulu Cao, Wenwen Zhang and Xiaoxiang Guan

    Version of Record online : 25 AUG 2015, DOI: 10.1111/jcmm.12662

  3. ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells

    The Prostate

    Volume 72, Issue 7, 15 May 2012, Pages: 777–788, Cécile Le Page, Ismaël Hervé Koumakpayi, Benjamin Péant, Nathalie Delvoye, Fred Saad and Anne-Marie Mes-Masson

    Version of Record online : 19 SEP 2011, DOI: 10.1002/pros.21483

  4. You have free access to this content
    Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer

    Cytometry Part A

    Volume 71A, Issue 5, May 2007, Pages: 273–285, Aparna S. Joshi, Girish M. Sharangpani, Kyle Porter, Sedigheh Keyhani, Carl Morrison, Amitabha S. Basu, Gauri A. Gholap, Abhi S. Gholap and Sanford H. Barsky

    Version of Record online : 23 FEB 2007, DOI: 10.1002/cyto.a.20374

  5. You have free access to this content
    The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis

    Arthritis & Rheumatology

    Volume 67, Issue 9, September 2015, Pages: 2415–2426, Patrícia Costa-Reis, Pierre A. Russo, Zhe Zhang, Lucrezia Colonna, Kelly Maurer, Stefania Gallucci, Steffan W. Schulz, Adnan N. Kiani, Michelle Petri and Kathleen E. Sullivan

    Version of Record online : 26 AUG 2015, DOI: 10.1002/art.39219

  6. You have free access to this content
    Do we need HER-2/neu testing for all patients with primary breast carcinoma?

    Cancer

    Volume 98, Issue 12, 15 December 2003, Pages: 2547–2553, Susanne Taucher, Margaretha Rudas, Robert M. Mader, Michael Gnant, Peter Dubsky, Thomas Bachleitner, Sebastian Roka, Florian Fitzal, Daniela Kandioler, Emanuel Sporn, Josef Friedl, Martina Mittlböck and Raimund Jakesz

    Version of Record online : 22 OCT 2003, DOI: 10.1002/cncr.11828

  7. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases

    British Journal of Surgery

    Volume 98, Issue 10, October 2011, Pages: 1408–1413, S. F. Schoppmann, B. Jesch, J. Zacherl, F. Wrba, M. Hejna, J. Maresch, F. B. Langer, M. F. Riegler, U. Pluschnig and P. Birner

    Version of Record online : 25 MAY 2011, DOI: 10.1002/bjs.7562

  8. You have free access to this content
    The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

    STEM CELLS

    Volume 16, Issue 6, November 1998, Pages: 413–428, Jeffrey S. Ross and Dr. Jonathan A. Fletcher

    Version of Record online : 1 NOV 1998, DOI: 10.1002/stem.160413

  9. Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation

    Molecular Carcinogenesis

    Volume 41, Issue 3, November 2004, Pages: 164–178, Javier A. Menendez, Inderjit Mehmi, Vishal A. Verma, Poh K. Teng and Ruth Lupu

    Version of Record online : 23 SEP 2004, DOI: 10.1002/mc.20054

  10. You have free access to this content
    HER-2: A biomarker at the crossroads of breast cancer immunotherapy and molecular medicine

    Journal of Cellular Physiology

    Volume 205, Issue 1, October 2005, Pages: 10–18, Serenella M. Pupa, Elda Tagliabue, Sylvie Ménard and Andrea Anichini

    Version of Record online : 10 MAY 2005, DOI: 10.1002/jcp.20387

  11. You have free access to this content
    Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

    Cancer

    Volume 113, Issue 6, 15 September 2008, Pages: 1294–1301, Suhail M. Ali, Walter P. Carney, Francisco J. Esteva, Monica Fornier, Lyndsay Harris, Wolfgang. J. Köstler, Jean-Pierre Lotz, Diana Luftner, Marie-France Pichon and Allan Lipton

    Version of Record online : 25 JUL 2008, DOI: 10.1002/cncr.23689

  12. You have full text access to this Open Access content
    Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer

    Cancer Science

    Volume 101, Issue 9, September 2010, Pages: 2026–2032, Rabindra N. Bhattacharjee, Alexander V. Timoshenko, Jing Cai and Peeyush K. Lala

    Version of Record online : 14 JUN 2010, DOI: 10.1111/j.1349-7006.2010.01647.x

  13. A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases

    Journal of Oral Pathology & Medicine

    Volume 46, Issue 3, March 2017, Pages: 167–174, Liang Xia, Yuhua Hu, Jiang Li, Ting Gu, Chunye Zhang, Lizhen Wang and Zhen Tian

    Version of Record online : 16 JUL 2016, DOI: 10.1111/jop.12477

  14. You have free access to this content
    HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ

    Cancer

    Volume 118, Issue 17, 1 September 2012, Pages: 4354–4362, Anupama Sharma, Ursula Koldovsky, Shuwen Xu, Rosemarie Mick, Robert Roses, Elizabeth Fitzpatrick, Susan Weinstein, Harvey Nisenbaum, Bruce L. Levine, Kevin Fox, Paul Zhang, Gary Koski and Brian J. Czerniecki

    Version of Record online : 17 JAN 2012, DOI: 10.1002/cncr.26734

  15. You have free access to this content
    Inefficient proteasomal-degradation pathway stabilizes AP-2α and activates HER-2/neu gene in breast cancer

    International Journal of Cancer

    Volume 118, Issue 4, 15 February 2006, Pages: 802–811, Min Li, Yingqun Wang, Mien-Chie Hung and Perry Kannan

    Version of Record online : 17 AUG 2005, DOI: 10.1002/ijc.21426

  16. You have free access to this content
    HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes

    International Journal of Cancer

    Volume 87, Issue 3, 1 August 2000, Pages: 349–359, Barbara Seliger, Yang Rongcun, Derek Atkins, Silke Hammers, Christoph Huber, Stefan Störkel and Rolf Kiessling

    Version of Record online : 10 JUL 2000, DOI: 10.1002/1097-0215(20000801)87:3<349::AID-IJC7>3.0.CO;2-O

  17. You have free access to this content
    HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma

    Cancer Cytopathology

    Volume 99, Issue 5, 25 October 2003, Pages: 310–315, Cecilia Bozzetti, Nicola Personeni, Rita Nizzoli, Annamaria Guazzi, Marcella Flora, Cristina Bassano, Francesca Negri, Eugenia Martella, Nadia Naldi, Vittorio Franciosi and Stefano Cascinu

    Version of Record online : 9 SEP 2003, DOI: 10.1002/cncr.11731

  18. Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential

    The Prostate

    Volume 68, Issue 8, 1 June 2008, Pages: 830–838, Carmela Ricciardelli, Michael W. Jackson, Catherine S. Choong, Jürgen Stahl, Villis R. Marshall, David J. Horsfall and Wayne D. Tilley

    Version of Record online : 6 MAR 2008, DOI: 10.1002/pros.20747

  19. You have free access to this content
    HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors

    International Journal of Cancer

    Volume 108, Issue 4, 10 February 2004, Pages: 540–548, Elizabeth Half, Russell Broaddus, Kathleen D. Danenberg, Peter V. Danenberg, Gregory D. Ayers and Frank A. Sinicrope

    Version of Record online : 3 NOV 2003, DOI: 10.1002/ijc.11599

  20. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 7, July 2010, Pages: 1266–1275, Xin-Xin Zhou, Feng Ji, Jing-Li Zhao, Lin-Fang Cheng and Cheng-Fu Xu

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1440-1746.2010.06287.x